Login / Signup

Pulmonary function tests for evaluating the severity of Duchenne muscular dystrophy disease.

Hagit LevineItai GoldfarbJulia KatzMoriah CarmeliTzippy ShochatHuda MussaffiSharon AharoniDario PraisYoram Nevo
Published in: Acta paediatrica (Oslo, Norway : 1992) (2023)
Forced vital capacity, total lung capacity and transcutaneous carbon dioxide correlated with the clinical severity of disease in children with DMD. These measures may be useful in follow up and clinical trials. A comparable correlation was not found for peak cough flow.
Keyphrases
  • duchenne muscular dystrophy
  • carbon dioxide
  • clinical trial
  • young adults
  • muscular dystrophy
  • phase ii